[This review was originally posted at the Nieman Journalism Lab Cephalexin Cost, on July 22, 2011.]

Murdoch's damage-control efforts: As News Corp.'s hacking scandal continues to metastasize, it can be difficult to keep up with all the background, angles, and implications. The best one-stop source is Mallary Jean Tenore's explainer for Poynter, and I'll try to update you on all the developments of the past week.

The big event came on Tuesday, when Rupert Murdoch, his son James, Order Cephalexin online overnight delivery no prescription, and his former British chief Rebekah Brooks answered questions from Parliament about the scandal. The Guardian gave a great, quick rundown of what happened there, and the general theme was Murdoch's professed lack of knowledge of the illegal activity at his News of the World tabloid. That's what the Daily Beast's Howard Kurtz took away from it, and Slate's Jack Shafer noted that while the Murdochs kept playing the victim card, they wouldn't say who exactly victimized them, where can i buy Cephalexin online. That was all part of a calculated PR and legal defense, outlined by Nick Davies of the Guardian, Cephalexin Cost.

While many people obviously found the idea of a blissfully ignorant Murdoch family hard to believe, Reuters' Felix Salmon said their strategy was effective enough. Still, the scandal has led to some probing questions about the culture that the Murdochs have created at News Corp. The New York Times' David Carr documented a history of illegal and anticompetitive behavior in the company's American arm, About Cephalexin, and Poynter's Steve Myers called this a corporate corruption story in the Enron vein. In the Guardian, NYU prof Jay Rosen asserted that "News Corp is not a news company at all, but a global media empire that employs its newspapers – and in the US, Fox News – as a lobbying arm."

The episode also has implications beyond News Corp. itself: Media consultant Alan Mutter said it weakens the already damaged trust Cephalexin Cost, Americans have in the media, and the New York Times reported that media consolidation opponents are hoping it provides an opportunity to re-examine the problems in modern media ownership. Here at the Lab, Ken Doctor wrote about why media concentration should be a concern in the U.S., Cephalexin no rx, and the Online Journalism Review's Robert Niles said that's why he's rooting for News Corp. to fail.

So what's next for News Corp.. The long-term future of both Rupert and James Murdoch at the company was in question this week, though Rupert assured Parliament he'd be sticking around. Felix Salmon speculated that the whole company could be in play if things go sour, and CUNY j-prof Jeff Jarvis looked at one possible scenario resulting in a News Corp, Cephalexin Cost. Cephalexin from canadian pharmacy, news and publishing sell-off. Ken Doctor, meanwhile, said News Corp. might end up becoming a more American company as a result of the scandal.

Murdoch still has his defenders, though the most vocal of them at this point (aside from the New York Observer) are media outlets owned by Murdoch himself. Perhaps the most full-throated of those defenses came in the Wall Street Journal, ordering Cephalexin online, which ran numerous opinion pieces, including one equating the hacking with WikiLeaks and an editorial lashing out at Murdoch's critics. PaidContent's Staci Kramer said the Journal would have been better off Cephalexin Cost, spiking the editorial, and the Columbia Journalism Review's Ryan Chittum argued that the Journal's characterization of investigative reporting as ideologically motivated tells us a lot about the "intellectual bankruptcy" of the Journal's editorial page itself.

Even before the editorial, the New York Times' Joe Nocera said the whole paper had been "Fox-ified" — turned shallow and ideological — by Murdoch's influence. Ryan Chittum countered that the paper has declined under Murdoch, Is Cephalexin safe, but it's far from hopeless, and Journal staffers also defended themselves against the "Foxification" charge. Meanwhile, a Pew study found that the actual Fox News Channel is covering the scandal far less than its rivals, and the Guardian continued to earn praise for its coverage of the story, with editor Alan Rusbridger describing in Newsweek how they did it.

—

Should nonprofit news be more objective?: Pew's Project for Excellence in Journalism released a study this week examining the growing group of nonprofit news organizations, buy cheap Cephalexin, evaluating them specifically for ideological nature and transparency. The study found that of the several dozen new nonprofit sites covering state and national news it looked at, about half are clearly ideological, Cephalexin Cost. Poynter's Rick Edmonds wrote a good, quick summary, noting in particular that several of the most ideological sites offered no clue to their orientation in their names, and that the most productive sites tended to be the least ideological ones. What is Cephalexin, The Lab's Joshua Benton inferred the study's implicit message — the new nonprofit news isn't objective, can't be fully trusted, and especially not to replace newspapers. Benton pushed back against those conclusions, arguing that the new sites aren't meant to replace newspapers, and that their lack of objectivity doesn't keep them from being useful to society.

The Columbia Journalism Review's Greg Marx was a bit more pointed in his response, where can i find Cephalexin online, picking apart some of its examples and particularly the implicit conclusion that Benton identified: "The PEJ report is suffused throughout with a sense that it’s the obligation of the new non-profits to reincarnate as best they can the status quo ante ... But it’s worth remembering that, in many times and many places, the status quo ante wasn’t all that good."

—

Scribd to see if news will Float: Over the past year or so, we've seen several new attempts to charge for news online by aggregating news from a variety of news outlets, with services like Ongo and News.me. Cephalexin Cost, This week, the document-sharing site Scribd launched its own entry into that space with Float, a mobile reading app that allows users to read subscribers from a variety of sources — what it calls a "Netflix for news." Float launched a free version this week, but will introduce its paid subscription service this fall. Cephalexin duration, Float has a social media-oriented aspect and an Instapaper-like reading list, but as TechCrunch described, its main feature is its ability to present any type of page, from books to blogs to news articles, in the same uniform, easily browseable format. GigaOM's Colleen Taylor found the fluid presentation remarkable, comprar en línea Cephalexin, comprar Cephalexin baratos, but wondered if Float could get a critical mass of news sites to make it worth paying for. PaidContent's David Kaplan said that Float works like a hybrid between Instapaper and Pulse, but that it could try to sell publishers on the idea of picking up browsing readers, rather than devoted subscribers.

Meanwhile, Buy Cephalexin without prescription, another traditional media outlet moved forward with an online paid-content strategy: Time introduced a plan that allows readers to subscribe to a bundle of the magazine's print publication, mobile/tablet apps, and web version. As All Things D's Peter Kafka reported, that also includes shutting off magazine articles on the web from nonsubscribers, though most of the web content should remain free. David Kaplan of paidContent said while it's always an uphill battle to get readers to pay for news online, magazine publishers are aided by the fact that they're becoming more unified in charging for their tablet editions, Cephalexin Cost.

—

Big Google+ possibilities: As Google+ continues to grow, tech writers continue to think bigger about what it could end up being. O'Reilly Radar's Edd Dumbill said Google+ could be the program that connects people across the entirety of the web, just search does for information. "Google+ is the rapidly growing seed of a web-wide social backbone, Cephalexin price, coupon, and the catalyst for the ultimate uniting of the social graph," he wrote. Tim Carmody of Wired argued that Google+ is also part of the ramp-up to the coming "Cloud Wars" between Google and Microsoft.

We're starting to see more possibilities for Google+ and journalism, too: Mashable provided a list of ways journalists can use the service, Cephalexin brand name, and 10,000 Words put together a guide to Google+ and breaking news. Poynter's Jeff Sonderman said Google+ can teach news organizations some lessons Cephalexin Cost, about innovation and developing new products. Unfortunately, Google is removing many company/brand accounts from the service right now, including the innovative BreakingNews and KOMU-TV accounts.

—

Reading roundup: Here's what else we talked about this week:

— The Columbia Journalism published online its feature on the Journal Register Co. from earlier this summer, while the Lab's Martin Langeveld gave some smart analysis on what Alden Global Capital's purchase of the newspaper chain last week might mean for the company's media consolidation plans.

— Yesterday would have marked the 100th birthday of our best-known media theorist, Marshall McLuhan, and the Lab celebrated with some fantastic essays on his legacy by Megan Garber and Maria Bustillos. At the Guardian, Douglas Coupland wrote about why McLuhan still matters, Cephalexin Cost.

— NYU j-prof Jay Rosen and author Nicholas Carr finished their debate over whether the Internet has been good for journalism, and Rosen also expounded on five key works to understanding journalism in the Internet age.

— Three great pieces to read now ... or later ... whenever: Anil Dash on how to make sure the people using your website treat each other with decency, Paul Ford on the way Facebook defies the journalistic impulse to craft simple narratives, and Scott Rosenberg with a book (available free via PDF) on the new ethics of online journalism.

Similar posts: Cipro Over The Counter. Purchase Flagyl. Buy Bactrim No Prescription. About Glucophage. Where can i order Glucophage without prescription. Cipro brand name.
Trackbacks from: Cephalexin Cost. Cephalexin Cost. Cephalexin Cost. Cephalexin reviews. Buy Cephalexin no prescription. Cephalexin pics.

[This review was originally posted at the Nieman Journalism Lab Purchase Glucophage, on July 18, 2011.]

News Corp.'s scandal keeps growing: Rupert Murdoch might have hoped News Corp.'s phone hacking scandal would die down when he closed the British tabloid News of the World last week, but it only served to fuel the issue's explosion. This past week, the scandal's collateral damage spread to News Corp.'s proposed takeover of the British broadcaster BSkyB: Faced with increasing pressure from the British government and the revelation that News Corp. journalists tried to get private records of former Prime Minister Gordon Brown, News Corp. dropped the BSkyB bid, which had been a huge part of the company's U.K. strategy. Buy no prescription Glucophage online, Plenty of other problems are cropping up for News Corp., too. The top lawyer for its U.K, Purchase Glucophage. newspaper branch, News International, quit. The company's stock lost $7 billion in four business days at one point. A pre-existing U.S. shareholders' suit expanded to cover the hacking scandal, is Glucophage addictive. The Murdochs have to testify before British Parliament Purchase Glucophage, this week about the scandal, and the FBI started investigating U.S.-related aspects of the issue. That's all in addition to the ongoing problems News Corp. faces, as detailed by Poynter's Rick Edmonds.

The scandal has led quite a few writers to criticize the culture that Murdoch has created at News Corp. Capital New York's Tom McGeveran and Reuters' John Lloyd railed on Murdoch and News Corp.'s character, Carl Bernstein called this Murdoch's Watergate, Canada, mexico, india, and the Observer's editorial board called for systemic reforms in Britain so Murdoch's influence can never be so strong. Members of the Bancroft family said they wouldn't have sold the Wall Street Journal to Murdoch in 2007 if they'd have known the hacking was going on, Purchase Glucophage.

On the other hand, the New York Times pointed out that sleazy British tabloid tactics are hardly limited to Murdoch, and media critic Howard Kurtz noted that they're very much alive in the U.S. mainstream press, too. New York Times columnist Roger Cohen defended Murdoch, saying he's been good for journalism on the whole, purchase Glucophage online, and Gawker's John Cook defended those tabloid reporting tactics. Meanwhile, j-prof Jeff Jarvis and the Telegraph's Toby Harnden urged the British government not to respond by enacting more regulation. Purchase Glucophage, News Corp.'s retreat might not stop with News of the World and BSkyB. Murdoch biographer Michael Wolff and others have reported that the company's execs are debating whether to get out of Britain's newspaper business entirely, and several observers chimed in to say that might actually make a good deal of business sense. Media analyst Ken Doctor said News International is losing steam, After Glucophage, and the Financial Times' John Gapper said newspapers are becoming far more trouble than they're worth to Murdoch.

Not only that, but the New Yorker's John Cassidy said dropping his U.K. newspapers could let Murdoch revive his BSkyB bid, and Jeff Jarvis speculated that when Murdoch chooses between the power that the papers give him and the money saved by getting rid of them, he'll choose the money. In an interview with the Wall Street Journal, Murdoch called the rumors of a newspaper sell-off "rubbish."

But just because News of the World and News International may be dead and dying, that doesn't mean newspapers as a whole are, argued David Carr of the New York Times, Purchase Glucophage. As he noted, it was the Guardian's dogged reporting that finally broke this story open. Murdoch "prefers his crusades to be built on chronic ridicule and bombast, Glucophage used for. But as The Guardian has shown, the steady accretion of fact — an exercise Mr. Murdoch has historically regarded as bland and elitist — can have a profound effect," Carr wrote. The Atlantic also had praise for the Guardian, and Poynter's Mallary Jean Tenore interviewed one of its editors about the lonely journey of covering the phone hacking story.

—

HuffPo aggregation under the microscope Purchase Glucophage, : A lively discussion about the rights and wrongs of aggregation developed last week out of a column by Ad Age media critic Simon Dumenco, who complained that the Huffington Post had extensively summarized one of his posts, buried the link to the original, and — contrary to Arianna Huffington's argument that her site benefits those they aggregate by sending them readers — gave him just 57 page views. Buy Glucophage without a prescription, The Huffington Post responded by apologizing and suspending the article's writer. HuffPo business editor Peter Goodman told Adweek the piece was a fully formed article when it should have been a simple introduction and a link, but Dumenco responded to the apology by arguing that the writer did nothing out of the ordinary — this is just how HuffPo tells its writers to do it.

Dumenco's point was echoed by several others: The Awl's Choire Sicha said the suspended writer was doing what she was taught, Gawker's Ryan Tate, drawing on a revealing quote from a former HuffPo writer, made the same point: "This is pretty ridiculous, given HuffPo's systematic, Glucophage dosage, officially-sanctioned approach to rewriting too much of people's news articles." British journalist Kevin Anderson called HuffPo's summary-heavy aggregation "a pretty cynical strategy," and paidContent's Staci Kramer said HuffPo needs to respect its sources, rather than treating a link as a favor.

Gabe Rivera, whose news site, Techmeme, Where can i order Glucophage without prescription, was compared to HuffPo favorably by Dumenco, looked for terms to distinguish what his site does from what HuffPo does. Poynter's Julie Moos said some measure of originality will always make for better journalism and a better business model than heavy aggregation, and ZDNet's Tom Foremski pined for the old blogging mentality whose goal was to add value, Purchase Glucophage. In a short podcast, author Steven Rosenbaum said this is a logical time to step back and evaluate exactly what constitutes ethical aggregation.

There were a few dissenters, though: GigaOM's Mathew Ingram and Slate's Jack Shafer both argued that the type of aggregation that HuffPo does has been around for ages in traditional media (especially in Britain, according to Forbes' Tim Worstall). In fact, Glucophage coupon, Shafer said, news orgs could learn a something valuable from the Huffington Post: "That a huge, previously ignored readership out there wants its news hot, quick, and tight."

—

Comparing Google+, Facebook, Cheap Glucophage, and Twitter: It's been just about three weeks since Google+ launched, and Google's new social network is growing like a weed, with estimates of as many as 10 million users so far. (Its number of active users may soon be approaching Twitter's figures.) Google+ news has dominated Twitter, and Google's also working on integrating it with Gmail. Purchase Glucophage, With Plus' incredible growth, tech observers have been going back and forth about what social network Google+ is disrupting most. PCWorld's Megan Geuss wondered whether Google+ and Facebook can coexist, and PC Magazine's John Dvorak posited that all the excitement about Google+ is more or less just pent-up frustration with Facebook. The New York Times' David Pogue and Technology Review's Paul Boutin both compared Google+ favorably to Facebook, largely because of its superior privacy controls (though GigaOM's Mathew Ingram pointed out that it may not be a privacy improvement for some people).

Meanwhile, Search Engine Land's Danny Sullivan said Google+ is more comparable to Twitter, Glucophage natural, then went ahead and made a thorough, smart comparison between the two. The Atlantic's Alexis Madrigal said Google+ might end up being more conversational than Twitter, which he called more of a call-and-response: Google+ "won't be as good at connecting people to information or each other quickly, but it might be better at longer form discussions and whatever we call the process by which people pull reasoned thoughts from their networks into public discourse." Hutch Carpenter said Google+ resembles both Facebook and Twitter, and Computer World's Mike Elgan wrote that it'll disrupt just about everything.

Still, Google+ has its limits: ReadWriteWeb's Marshall Kirkpatrick explained why he'd never move his personal blog there as some are doing, and Instapaper's Marco Arment and the Guardian's Dan Gillmor both urged readers to keep a space for their own online identity outside of spaces like Google+ or Facebook, Purchase Glucophage. For journalists feeling out Google+, Meranda Watling of 10, Glucophage from canada,000 Words put together a preliminary guide.

—

Reading roundup: Here's what else people were talking about this past week:

— The newspaper chain MediaNews made a distinctive play for the tablet news market last week, announcing the launch of TapIn, a location-based news app made specifically for tablets. It'll start in the Bay Area in partnership with the San Jose Mercury News. Ken Doctor, Jeff Sonderman, Glucophage overnight, and Mathew Ingram all wrote about what makes it worth watching.

— The Economist continued running pieces all week in its series on the future of the news industry. You can check out several writers'reasons for optimism or read the opening statements in an ongoing debate between NYU's Jay Rosen and author Nicholas Carr about whether the Internet has been good for journalism.

— Boston Globe developer Andy Boyle made his pitch for young journalists to go into web development, or as he put it, "learn to make the internets."

— Poynter's Jeff Sonderman put together two great social media how-to's for journalists: One on verifying information on social media, and the other on strategies for engagement on Facebook.

— Finally, NYU's Clay Shirky gave us another thoughtful essay on the unbundling of news and why the news ecosystem needs to be chaotic right now. In the end, though, here's what he believes news should be: "News has to be subsidized because society’s truth-tellers can’t be supported by what their work would fetch on the open market"; "news has to be cheap because cheap is where the opportunity is right now"; and "news has to be free, because it has to spread.".

Similar posts: Zoloft No Rx. Bactrim For Sale. Glucophage Price. Tramadol coupon. Glucophage for sale. Cephalexin reviews.
Trackbacks from: Purchase Glucophage. Purchase Glucophage. Purchase Glucophage. Glucophage dose. Buying Glucophage online over the counter. Rx free Glucophage.